Karl Kashofer

8PUBLICATIONS
35CO-AUTHORS
Cancer geneticsPredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 06, 2026
Genetic analysis of primary lung interdigitating dendritic cell sarcomas.

|Jan 09, 2026
Functional footprints of homologous recombination deficiency in prostate cancer revealed by ctDNA fragmentation and transcription factor accessibility.

Georgios Vlachos, Tina Moser, Isaac Lazzeri

|Nov 13, 2025
Resurfacing Threats: Metastatic Ossifying Fibromyxoid Tumor Emerging After Almost Two Decades.

Mario Ambros, Bernadette Liegl-Atzwanger, Karl Kashofer

|Nov 11, 2024
Acute myeloid leukemia in the next-generation sequencing era : Real-world data from an Austrian tertiary cancer care center.

Sonja Wurm, Michael Waltersdorfer, Simone Loindl

|Feb 22, 2023
Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilities.

Johannes Foßelteder, Gabriel Pabst, Tommaso Sconocchia

|Feb 16, 2021
EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivity.

Johannes Lorenz Berg, Bianca Perfler, Stefan Hatzl

Pageof 2

Frequent Collaborators

4 joint publications

Armin Zebisch

4 joint publications

Heinz Sill

3 joint publications

Albert Wölfler

3 joint publications

Gerald Hoefler